⌘+K

Pulse Explore Clubs Researchers Journals

Home Clubs Explore

September 4, 2024

Table S1 from A Next-Generation BRAF Inhibitor Overcomes Resistance to BRAF Inhibition in Patients with BRAF-Mutant Cancers Using Pharmacokinetics-Informed Dose Escalation

Rona Yaeger Meredith McKean Rizwan Haq J. Thaddeus Beck Matthew H. Taylor Jonathan Cohen Daniel W. Bowles Shirish M. Gadgeel Catalin Mihalcioiu Kyriakos P. Papadopoulos Eli L. Diamond Keren Sturtz Gang Feng Stefanie K. Drescher Micaela B. Reddy Bhaswati Sengupta Arnab K. Maity Suzy A. Brown Anurag Singh Eric N. Brown Brian R. Baer Jim Wong Tung‐Chung Mou Wen‐I Wu D Kahn Sunyana Gadal Neal Rosen John J. Gaudino Patrice A. Lee Dylan P. Hartley S. Michael Rothenberg

View Full Paper

Ask AI

Bookmark

Share

No abstract yet

We only have this paper's title and publication details.

Read it at the source→

Abstract

Table S1. Cell lines used for cell-based pERK assays in Figure 1A

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Yaeger et al. (2024) studied this question.

synapsesocial.com/papers/68e5968ab6db6435875312ab https://doi.org/10.1158/2159-8290.26935050

View Full Paper

Ask AI

Bookmark

Share

Keep reading

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1Table S1 from A Next-Generation BRAF Inhibitor Overcomes Resistance to BRAF Inhibition in Patients with <i>BRAF</i>-Mutant Cancers Using Pharmacokinetics-Informed Dose Escalation2024
2Table S5 from A Next-Generation BRAF Inhibitor Overcomes Resistance to BRAF Inhibition in Patients with <i>BRAF</i>-Mutant Cancers Using Pharmacokinetics-Informed Dose Escalation2024
3Table S5 from A Next-Generation BRAF Inhibitor Overcomes Resistance to BRAF Inhibition in Patients with <i>BRAF</i>-Mutant Cancers Using Pharmacokinetics-Informed Dose Escalation2024
4Table S3 from A Next-Generation BRAF Inhibitor Overcomes Resistance to BRAF Inhibition in Patients with <i>BRAF</i>-Mutant Cancers Using Pharmacokinetics-Informed Dose Escalation2024
5Table S3 from A Next-Generation BRAF Inhibitor Overcomes Resistance to BRAF Inhibition in Patients with <i>BRAF</i>-Mutant Cancers Using Pharmacokinetics-Informed Dose Escalation2024